Voleon Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Voleon Capital Management's ABUS Position: Q3 2026 in Review
Voleon Capital Management sold out of Arbutus Biopharma (ABUS) in Q3 2026, closing a stake of 19,741 shares — an estimated $94.8K sold.
Voleon Capital Management first reported a position in ABUS in Q3 2025 and held it in 3 quarters. The position peaked at $94.8K in Q2 2026. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Voleon Capital Management reported no remaining Arbutus Biopharma position as of Q3 2026 after selling out during the quarter.
- Voleon Capital Management sold 19,741 Arbutus Biopharma shares in Q3 2026, an estimated $94.8K.
- Voleon Capital Management first reported a position in Arbutus Biopharma in Q3 2025 and held it in 3 quarters.
- Voleon Capital Management's Arbutus Biopharma position peaked at $94.8K in Q2 2026.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.